The Role of hCG in Thawed Embryo Transfer

Part of paid clinical trials in Las Vegas, Nevada.

Sponsor
Fertility Center of Las Vegas
Study ID
NCT07004192
Phase
PHASE4
Status
Recruiting
Apply to this trial

Conditions

  • Infertility (IVF Patients)

Eligibility Criteria

Sex
FEMALE
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • HCG injection — DRUG
    5000 IU hCG injection
  • No intervention — OTHER
    No hCG administered in this group.

Study Details

This prospective randomized trial will assess the relevance, if any, of a corpus luteum induced by hCG in transfers of thawed embryos.

Key Dates

Start date
Jun 2, 2025
Status verified
Jun 2025
Primary completion
Dec 31, 2027
Completion
Dec 31, 2027

Study Design

Enrollment
220 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: hCG Group
    This group receives one injection of hCG.
  • Active Comparator: No hCG Group
    This arm receives no hCG.

Primary Outcome Measure

Blood pressure [ Time Frame: Third trimester of pregnancy ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Fertility Center of Las VegasLas VegasNevada89113
Shironda Research Assistant
[email protected]
702-254-1777

Find similar trials in Las Vegas, NV

By research site
Fertility Center of Las Vegas· Las Vegas, NV

Related Studies